Filtered By:
Specialty: Cancer & Oncology
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 307 results found since Jan 2013.
Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" Vaccine 40(41) (2022) 5971-5996
Vaccine. 2023 Sep 1:S0264-410X(23)00787-9. doi: 10.1016/j.vaccine.2023.06.084. Online ahead of print.NO ABSTRACTPMID:37659892 | DOI:10.1016/j.vaccine.2023.06.084
Source: Cancer Control - September 2, 2023 Category: Cancer & Oncology Authors: Matthew Palmer Kota Katanoda Eiko Saito Cecilia Acuti Martellucci Shiori Tanaka Sayaka Ikeda Haruka Sakamoto Dorothy Machalek Julia M L Brotherton Jane S Hocking Source Type: research
Parental intention to vaccinate daughters with the human papillomavirus vaccine in Korea: a nationwide cross-sectional survey
CONCLUSION: The intention among parents to vaccinate daughters remains relatively low, although it is rising. To increase the HPV vaccination rate, strong recommendations and education should be provided to parents and the younger generation.PMID:37591785 | DOI:10.4178/epih.e2023076
Source: Cancer Control - August 17, 2023 Category: Cancer & Oncology Authors: Yejin Ha Kyeongmin Lee Bomi Park Mina Suh Jae Kwan Jun Kui Son Choi Source Type: research
Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein
PLoS One. 2023 Aug 15;18(8):e0290088. doi: 10.1371/journal.pone.0290088. eCollection 2023.ABSTRACTCervical cancer represents a global concern with 604,000 new cases and 342,000 deaths reported annually, with the vast majority diagnosed in low income countries. Despite high-risk Human Papillomavirus (HR HPV)-induced cervical cancer has become highly preventable through prophylactic vaccines, screening programs are critical in the control of cervical carcinogenesis in populations with limited access to vaccination and in older generations of women who have already been exposed to HR HPV infection. The surge of HPV molecular ...
Source: Cancer Control - August 15, 2023 Category: Cancer & Oncology Authors: Natalia E Contreras Julieta S Rold án Daniela S Castillo Source Type: research
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
CONCLUSIONS: TTMV-HPV DNA surveillance testing yields few false negative results and few missed recurrences. These data could inform decisions on when to pursue re-imaging following first disease restaging and could inform future surveillance practice. Additional study of how pre-treatment TTMV-HPV DNA status impacts sensitivity for recurrence is needed.PMID:37566241 | DOI:10.1158/1078-0432.CCR-23-1478
Source: Clinical Cancer Research - August 11, 2023 Category: Cancer & Oncology Authors: Glenn J Hanna Scott A Roof James Jabalee Eleni M Rettig Rocco Ferrandino Sida Chen Marshall R Posner Krzysztof J Misiukiewicz Eric M Genden Raymond L Chai John Sims Elaine Thrash Scott J Stern Noah S Kalman Sreenija Yarlagadda Adam Raben Lydia Clements Ab Source Type: research
Breast and gynecologic cancers as a Brazilian health priority
CONCLUSION: Analyzed together, breast and gynecologic cancers correspond to the leading cause of cancer in Brazil. A heterogeneous group, female cancer includes diseases with a high primary and secondary prevention potential. The organization of a female cancer program in Brazil prioritizing primary and secondary prevention strategies, such as adequate mammography screening and human papillomavirus vaccination coverage, could significantly improve female cancer control in the country.PMID:37556639 | DOI:10.1590/1806-9282.2023S120
Source: Cancer Control - August 9, 2023 Category: Cancer & Oncology Authors: Ang élica Nogueira-Rodrigues Daniela Dornelles Rosa Daniele Assad Suzuki Eduardo Paulino Luciana Castro Garcia Landeiro Mariana Scaranti Marisa Riscalla Madi Paulo Marcelo Hoff Source Type: research
Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of Anal Intraepithelial Neoplasia in HIV+ Men
CONCLUSIONS: The highest dose level is safe, immunogenic and associated with clinical responses to HPV16-induced lesions. However, as the majority of HGAIN is caused by the other HPV types, further studies should aim at pan-HPV vaccination to prevent or treat HGAIN.PMID:37540563 | DOI:10.1158/1078-0432.CCR-22-3361
Source: Clinical Cancer Research - August 4, 2023 Category: Cancer & Oncology Authors: Karien C M Gosens Sjoerd H van der Burg Marij J P Welters Sanne Boekestijn Nikki M Loof Wim G V Quint Carel J M van Noesel Allard C van der Wal Olivier Richel Wilhelmus J T A Krebber Cornelis J M Melief Henry J C de Vries Jan M Prins Source Type: research
Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward - a meeting report
This report covers some critical findings, key challenges, and future steps to improve the status of HPV prevention and control measures in the country.PMID:37537651 | DOI:10.1186/s12919-023-00271-0
Source: Cancer Control - August 3, 2023 Category: Cancer & Oncology Authors: Dur-E-Nayab Waheed Catherine Weil Olivier Didier Riethmuller Eduardo L Franco Jean Luc Pr étet Marc Baay Nubia Munoz Alex Vorsters Source Type: research
Natural and synthetic drugs and formulations for intravaginal HPV clearance
CONCLUSIONS: This article may serve as a valuable resource of information for managing and preventing precancerous carcinogenic HPV infections. Research could be directed toward developing candidate drugs to make evidence-based decisions about advancing them to clinical trials and, eventually, to the market for potential use in the prevention and control of cervical cancer, which is almost always preventable or even curable if detected early.PMID:37535995 | DOI:10.1016/j.jiph.2023.06.016
Source: Cancer Control - August 3, 2023 Category: Cancer & Oncology Authors: Nizar A Khamjan Saba Beigh Abdullah Algaissi Kanu Megha Mohtashim Lohani Majid Darraj Nader Kamli Faisal Madkhali Sajad Ahmad Dar Source Type: research
Racial, Ethnic, and Gender Differences in the Timing of Initiating the HPV Vaccine in the United States: the Case of Southeast Asian Americans
J Racial Ethn Health Disparities. 2023 Aug 2. doi: 10.1007/s40615-023-01689-0. Online ahead of print.ABSTRACTDespite the availability of the human papillomavirus (HPV) vaccine, non-Latinx (NL) Southeast Asian Americans have the highest incidence of HPV-associated cervical cancer in the US. Little is known about NL-Southeast Asian Americans' HPV vaccination coverage due to being categorized under the "Asian American" monolith. Therefore, this study uses restricted data from the 2011-2018 National Health and Nutrition Examination Survey (NHANES) to disaggregate NL-Southeast Asian Americans and compare this population's age-s...
Source: Cancer Control - August 2, 2023 Category: Cancer & Oncology Authors: Kim-Phuong Truong-Vu Source Type: research
The Clinical Utility of Circulating HPV DNA Biomarker in Oropharyngeal, Cervical, Anal, and Skin HPV-Related Cancers: A Review
Pathogens. 2023 Jul 5;12(7):908. doi: 10.3390/pathogens12070908.ABSTRACTHuman papillomavirus (HPV) is recognized as being related to a wide variety of known cancers: cervical, oropharyngeal, anal, vaginal, penile, and skin. For some of these cancers, rigorous algorithms for screening, therapeutical interventions, and follow-up procedures have been established. Vaccination using the nonvalent anti-HPV vaccine, which prevents infection regarding the most frequently involved high-risk HPV types (16, 18, 31, 33, 45, 52, and 58) and low-risk HPV types (6 and 11), has also extensively prevented, controlled, and even eradicated H...
Source: Cancer Control - July 29, 2023 Category: Cancer & Oncology Authors: Ioana Maria Andrioaie Ionut Luchian Costin D ămian Giorgio Nichitean Elena Porumb Andrese Theodor Florin Pantilimonescu Bogdan Trandab ăț Liviu Jany Prisacariu Dana Gabriela Budal ă Daniela Cristina Dimitriu Luminita Smaranda Iancu Ramona Gabriela Urs Source Type: research
Frequency of health care provider recommendations for HPV vaccination: a survey in three large cities in China
DISCUSSION: The frequency of HCPs' recommendations for HPV vaccination in China was much lower than that in many developed countries. To enhance the recommendation frequency, medical institutions should help HCPs gain more knowledge of HPV and master communication skills. At the same time, the government should take measures to enhance the accessibility of HPV vaccines. The media should help to alleviate people's concerns and encourage them to face up sexual health.PMID:37497028 | PMC:PMC10366465 | DOI:10.3389/fpubh.2023.1203610
Source: Cancer Control - July 27, 2023 Category: Cancer & Oncology Authors: Yimeng Mao Yuchen Zhao Lingyun Zhang Jie Li Abu S Abdullah Pinpin Zheng Fan Wang Source Type: research
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial
This study aimed to compare the immunogenicity of the E coli-produced HPV 9-valent vaccine Cecolin 9 (against HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58) with Gardasil 9.METHODS: This was a randomised, single-blind trial conducted in China. Healthy non-pregnant women aged 18-26 years, who were not breastfeeding and with no HPV vaccination history, were enrolled in the Ganyu Centre for Disease Control and Prevention (Lianyungang City, Jiangsu Province, China). Women were stratified by age (18-22 years and 23-26 years) and randomly assigned (1:1) using a permutated block size of eight to receive three doses of Cecolin 9 or Ga...
Source: Cancer Control - July 20, 2023 Category: Cancer & Oncology Authors: Feng-Cai Zhu Guo-Hua Zhong Wei-Jin Huang Kai Chu Li Zhang Zhao-Feng Bi Kong-Xin Zhu Qi Chen Ting-Quan Zheng Ming-Lei Zhang Sheng Liu Jin-Bo Xu Hong-Xing Pan Guang Sun Feng-Zhu Zheng Qiu-Fen Zhang Xiu-Mei Yi Si-Jie Zhuang Shou-Jie Huang Hui-Rong Pan Ying-Y Source Type: research
